Molecular Partners AG

NASDAQ:MOLN

Biotechnology

Healthcare
$2.67 +0.77%

+$0.03 today

Market cap
$100.28M
Beta
0.71
P/E (TTM)
-2.0
EPS (TTM)
-$1.55
52W Low $3.41High $5.36

Volume 0.00M

Average 0.00M

Balance Sheet

Inspect the capital base behind the business.

Assets

$102.11M

FY 2025 · Annual

-35.6% YoY

Liabilities

$21.77M

FY 2025 · Annual

+28.9% YoY

Equity

$80.33M

FY 2025 · Annual

-43.3% YoY

Balance Sheet

CHF
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents71.81M87.95M67.31M63.87M82.65M
Short-term Investments61M161.2M119.58M85.57M10.41M
Net Receivables25.73M1.7M1.75M286K1.91M
Inventory20000
Other Current Assets0002.31M(1K)
Total Current Assets164.19M254.75M192.46M154.28M96.88M
Property, Plant & Equipment (Net)8.15M7.24M5.68M4.2M5.23M
Goodwill00000
Intangible Assets330K271K212K49K2K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1K(7.51M)000
Total Non-current Assets8.48M7.51M5.89M4.25M5.23M
Total Assets172.67M262.26M198.35M158.53M102.11M
Account Payables4.86M997K410K679K937K
Short-term Debt00000
Tax Payables855K0000
Deferred Revenue28.31M6.41M4.33M00
Other Current Liabilities00001K
Total Current Liabilities46.87M17.25M14.42M10.79M11.03M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)6.93M3.64M000
Other Non-current Liabilities6.74M2.55M5.06M4.88M8.31M
Total Non-current Liabilities18.51M9.84M7.51M6.11M10.75M
Total Liabilities65.38M27.09M21.92M16.89M21.77M
Common Stock3.23M3.6M3.64M4.04M4.04M
Retained Earnings(250.95M)(127.78M)(191.76M)(246.29M)(311.75M)
Accumulated OCI0(981K)000
Other Stockholders Equity0(0)(0)00
Minority Interest00000
Total Equity107.29M235.17M176.43M141.64M80.33M
Total Debt6.04M4.85M3.65M2.44M3.64M
Net Debt(65.77M)(83.1M)(63.66M)(61.43M)(79.01M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$78.5M
Short-term Investments$14.5M
Receivables$2.3M
Other Current-$12.7M
Total Current Assets$82.7M
PP&E (Net)$4.7M
Intangible Assets$997
Other Non-current-$0
Total Non-current Assets$4.7M
Total Assets$87.4M

Analysis

Selected assets total $87.4M for Latest. The largest visible component is Cash & Equivalents at $78.5M, about 89.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingOct 29, 2026
6-K6-K filingAug 25, 2026
6-K6-K filingJul 20, 2026
6-K6-K filingJul 7, 2026
6-K6-K filingJul 2, 2026

How much cash does MOLN have?

Molecular Partners AG (MOLN) reported $82.65M in cash and equivalents in fiscal 2025.

How much debt does MOLN carry?

Molecular Partners AG (MOLN) reported $3.64M of total debt, with net debt of -$79.01M.